This announcement is a separate document:
デンカ：海外連結子会社におけるノロウイルスワクチン開発中止および特別損失の計上に関するお知らせ
Denka: Notice regarding cancellation of norovirus vaccine development and recording of extraordinary losses at overseas consolidated subsidiaries
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.